Prior authorization automation: how to get budget approved by your CFO
You already know prior authorization is bleeding time and money. The problem is that knowing it is not the same as proving it in the language finance approves budget in. This guide walks through building the cost-of-status-quo number, modeling the return conservatively, and answering the three objections finance will raise, so the request that is obviously right to you becomes obviously right to the person who controls the budget.
Loading audio...
You already know prior authorization is bleeding time and money. The problem is that knowing it is not the same as proving it in the language finance approves budget in. When you bring an automation request to a CFO, a story about staff frustration and delayed care does not move the number. A model does. Finance funds projects that show a credible cost of the status quo, a defensible return, and an honest accounting of risk. This guide is about building that case, so the request that is obviously right to you becomes obviously right to the person who controls the budget.
The short version
- Finance does not fund frustration, it funds a model: the measured cost of the current process, a defensible return, and an honest view of the risk.
- Build the cost-of-status-quo number from staff time, denial rework, delayed or lost revenue, and turnover, using your own volumes against published benchmarks.
- Expect three objections, can we just hire instead, what if it does not work, and why now, and have the answer to each before the meeting.
Why does the prior authorization automation business case stall at finance?
Because it usually arrives as a qualitative complaint, not a quantitative case. Operations knows the pain viscerally: the hours on hold, the denials, the patients waiting. Finance does not feel that pain, it reads a P&L. When the request is framed as “this is exhausting and we need help,” the CFO hears a cost with no quantified return and defers it. The case stalls not because finance disagrees that prior authorization is painful, but because no one translated the pain into the cost and return figures finance needs to say yes. The fix is translation, not louder advocacy.
What does your CFO want to see?
Three things, in this order. The cost of the status quo, in dollars, using your own numbers. The expected return, stated conservatively, with the assumptions visible. And a clear-eyed account of the risk, including what happens if adoption is slower than hoped. A CFO trusts a model that shows its work and names its uncertainties far more than one that promises a clean number with no inputs. Bring the spreadsheet they are asking for, built on your data, and you have met them where decisions get made.
How do you build the cost-of-the-status-quo number?
Add up four cost drivers, using your volumes against published benchmarks. The benchmarks below are the anchors; your practice's actual figures go in the model.
| Cost driver | Benchmark anchor | Source |
|---|---|---|
| Physician and staff time on prior authorization | About 13 physician hours per week, plus staff time | AMA |
| Reworking denied claims | $25 to $118 per denied claim | HFMA |
| Lost revenue from unworked denials | About 65% of denials never resubmitted | Industry / AHA |
| Rising authorization volume | The large majority of physicians report PA volume increasing | AMA |
Plug your own numbers in: your authorization volume, your blended labor cost per hour, your denial rate, your average reimbursement per delayed or lost case. The output is the annual cost your practice is already paying to run prior authorization by hand. That number, built from your data, is the spine of the case. The detail behind these drivers is in our breakdown of the cost of manual prior authorization.
How do you model the return?
Keep it conservative and transparent. Model the return as the labor hours automation gives back, the denials recovered because they finally get worked, and the revenue protected by faster, cleaner authorizations. State each as a range, not a point, and show the assumption behind it. Then compare the modeled annual benefit against the annual cost of the platform to get a payback period and a return multiple. A CFO will trust a conservative model with a clear payback far more than an aggressive one with a big headline number, because the conservative version survives scrutiny in the room. If the conservative case clears the bar, the realistic case is upside.
What objections will finance raise, and how do you answer them?
Three, predictably. “Can we just hire instead of buying software?” Answer with the math: another coordinator adds fixed cost that scales linearly with volume and still leaves the routine work manual, while automation absorbs the volume without the linear headcount, which is the comparison we lay out in outsource versus automate. “What if it does not deliver?” Answer with the conservative model and a staged rollout that proves value on a subset before full commitment. “Why now, and not next year?” Answer with the rising-volume trend and the fact that the cost of the status quo compounds every quarter you wait. Walk in with these three answered and the meeting goes differently.
Where this case is strongest, and where it is weaker
This business case is strongest for practices with high authorization volume and a measurable denial rate, where the cost of the status quo is large and the return is easy to model: specialty practices, multi-site groups, and PE-backed portfolios where the savings roll up across locations. The bigger your authorization burden, the more the model favors automation.
It is weaker for a practice with low authorization volume, where the status-quo cost is small enough that the payback period stretches out and finance may reasonably prioritize elsewhere. The honest move there is to run the model and let it tell the truth. If the numbers do not clear the bar, the case is not ready, and presenting an inflated one only costs you credibility for the next request.
How Linear Health helps you make the case
Linear Health automates the prior authorization workflow end to end, which is what produces the labor savings, denial recovery, and faster decisions the business case is built on. Just as useful at the budget stage, it gives you the inputs the model needs: your authorization volume, your denial patterns, and the time spent per request, so the case rests on your data rather than generic assumptions. Customers see up to 80 percent less manual authorization time, and that figure, applied to your numbers, is usually what turns the CFO conversation from a deferral into an approval.
“I run this practice and I sign the checks, so I knew the automation case had to survive my own finance scrutiny, not just operations enthusiasm. What got it approved was a conservative model built on our real authorization volume and denial rate. Once the payback was on one page in numbers I trusted, the decision made itself.”
Frequently asked questions
How do I justify prior authorization automation to my CFO?
Translate the pain into a model: the measured annual cost of running prior authorization by hand (staff time, denial rework, lost revenue), a conservative return, and an honest account of risk. Finance funds defensible models, not qualitative complaints.
What should a prior authorization ROI model include?
The cost of the status quo built from your own volumes and labor costs, the modeled return as a range (labor recovered, denials recovered, revenue protected), and a payback period comparing benefit to platform cost. Show your assumptions so the model survives scrutiny.
Is it cheaper to hire a coordinator or automate prior authorization?
Hiring adds fixed cost that scales with volume and leaves the routine work manual. Automation absorbs the volume without linear headcount growth. For practices with rising authorization volume, the automation math usually wins, but the right answer is to run your own numbers.
What is the ROI of prior authorization automation?
It depends on your authorization volume, denial rate, and labor cost, which is why a model on your data beats a generic figure. The drivers are labor hours recovered, denials that finally get worked, and revenue protected by faster, cleaner authorizations.
How do I answer the “what if it doesn't work” objection?
Present a conservative model that still clears the bar, and propose a staged rollout that proves value on a subset of volume before full commitment. That reframes the risk from a leap of faith into a measured test.
Sami scaled Simple Online Healthcare to $150M and built a multi-specialty telehealth clinic across 20 specialties and all 50 states. Connect on LinkedIn.
